FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097174 [Registered on: 11/11/2025] Trial Registered Prospectively
Last Modified On: 08/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of two drugs added to local anaesthetic for pain relief in children undergoing cleft palate surgeries.  
Scientific Title of Study   Comparative Evaluation of dexmedetomidine versus dexamethasone as an adjuvant to bupivacaine in bilateral suprazygomatic maxillary nerve block for postoperative analgesia in children undergoing cleft palate surgeries : A Randomized, Prospective, Double-Blind Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Amanpreet Singh 
Designation  Junior Resident  
Affiliation  AIIMS New Delhi 
Address  Department of ANAESTHESIOLOGY AIIMS New Delhi, Ansari nagar east , New delhi, 110029

New Delhi
DELHI
110029
India 
Phone  8491934981  
Fax    
Email  166oberoi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sneha Singh 
Designation  Assistant Professor  
Affiliation  AIIMS New Delhi 
Address  Department of ANAESTHESIOLOGY AIIMS New Delhi, Ansari nagar east , New delhi, 110029

New Delhi
DELHI
110029
India 
Phone  9919625952  
Fax    
Email  drsinghsneha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Amanpreet Singh 
Designation  Junior Resident  
Affiliation  AIIMS New Delhi 
Address  Department of ANAESTHESIOLOGY AIIMS New Delhi, Ansari nagar east , New delhi, 110029

New Delhi
DELHI
110029
India 
Phone  8491934981  
Fax    
Email  166oberoi@gmail.com  
 
Source of Monetary or Material Support  
AIIMS NEW DELHI 
 
Primary Sponsor  
Name  AIIMS New Delhi 
Address  AIIMS New Delhi, Ansari Nagar East , New Delhi ,110029 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
AIIMS New Delhi  AIIMS ,Ansari Nagar East , New Delhi , 110029,INDIA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Amanpreet Singh  AIIMS New Delhi, Burns And Plastic Surgery block   Operation Theatre Complex, 7th floor, Burns and Plastic Surgery Block, AIIMS New Delhi, Ansari nagar east , New delhi, 110029
New Delhi
DELHI 
08491934981

166oberoi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Q00-Q99||Congenital malformations, deformations and chromosomal abnormalities,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Group DM   will receive 1-2 mL of a solution containing 0.15 mL /kg of 0.25% bupivacaine with 0.1 mg/kg of dexamethasone on each side  
Intervention  Group DX  will receive 1-2 mL of a solution containing 0.15 mL /kg of 0.25% bupivacaine with 0.5 µg /kg of dexmedetomidine on each side  
 
Inclusion Criteria  
Age From  8.00 Month(s)
Age To  5.00 Year(s)
Gender  Both 
Details  Children posted for elective cleft palate repair under general anaesthesia
Aged between 8 months to 5 years
ASA category I and II
Willing to give consent
 
 
ExclusionCriteria 
Details  Lack of Parental consent
Allergic to local anesthetics
Coagulation disorders
Local infection or lesion at the proposed puncture site
Language difficulties
Cognitive disorders
Comorbid conditions like congenital heart diseases airway obstruction disease and central nervous system disorders
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Time for first rescue analgesia
Duration of analgesia
 
Time for first rescue analgesia 24 hours
duration of analgesia 24 hours

 
 
Secondary Outcome  
Outcome  TimePoints 
Postoperative FLACC score
Total Postoperative fentanyl consumption
Parental satisfaction scale (LIKERT)
Intraoperative & total opioid use  
4HRS 8HRS 16HRS 20HRS 24HRS
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   20/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized, prospective, double-blind clinical trial designed to compare the effectiveness of dexmedetomidine and dexamethasone as adjuvants to bupivacaine in bilateral suprazygomatic maxillary nerve blocks for providing postoperative analgesia in children undergoing cleft palate surgery. The aim is to evaluate which adjuvant offers superior pain relief, longer duration of analgesia, and better safety profile in the pediatric population, thereby contributing to improved postoperative outcomes and reduced need for systemic analgesics. 
Close